On September 10, 2026 GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, reported that management will participate in the upcoming H.C. Wainwright 28th Annual Global Investment Conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:
H.C. Wainwright 28th Annual Global Investment Conference
Date: September 15, 2026, at 11:00am ET
Location: New York City, NY
Format: Presentation and 1 on 1 meetings

The presentation / webcast replay will be accessible through the "Events and Presentations" page of the Investor Relations section of the Company’s website at https://ir.genfit.com/.

(Press release, Genfit, SEP 10, 2026, https://ir.genfit.com/news-releases/news-release-details/genfit-participate-hc-wainwright-28th-annual-global-investment [SID1234670731])